CD274 and cancer: Therefore, both increased TIL levels and increased expression of PD-L1 in the tumor tissues can serve as surrogate biomarkers of immunogenicity of cancer cells and interactions between cancer cells and immune cells or of the presence of adaptive immune resistance [58, 60, 61].